NCT06088134 Contrast-enhanced CT-based Deep Learning Model for Preoperative Prediction of Disease-free Survival (DFS) in Localized Clear Cell Renal Cell Carcinoma (ccRCC)
| NCT ID | NCT06088134 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mingzhao Xiao |
| Condition | Clear Cell Renal Cell Carcinoma |
| Study Type | OBSERVATIONAL |
| Enrollment | 800 participants |
| Start Date | 2022-09-01 |
| Primary Completion | 2025-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 800 participants in total. It began in 2022-09-01 with a primary completion date of 2025-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to preoperatively predict DFS of patients with localised ccRCC using a deep learning prognostic model based on enhanced contrast CT images, validate it's predictive ability in multicentre data and compare it's predictive ability with traditional models.
Eligibility Criteria
Inclusion Criteria: * underwent partial/radical nephrectomies * histologically diagnosed as ccRCC * with complete clinical data and preoperative CT image data Exclusion Criteria: * with incomplete clinic-pathological data * lack of preoperative contrast-enhanced CT images or the image quality was unsuitable for analysis * who received pre-surgery neoadjuvant or adjuvant therapies * with multiple renal tumors or/and had synchronous metastasis
Frequently Asked Questions
Who can join the NCT06088134 clinical trial?
This trial is open to participants of all sexes, studying Clear Cell Renal Cell Carcinoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06088134 currently recruiting?
Yes, NCT06088134 is actively recruiting participants. Visit ClinicalTrials.gov or contact Mingzhao Xiao to inquire about joining.
Where is the NCT06088134 trial being conducted?
This trial is being conducted at Chongqing, China.
Who is sponsoring the NCT06088134 clinical trial?
NCT06088134 is sponsored by Mingzhao Xiao. The trial plans to enroll 800 participants.